Incorporating Remote Symptom Monitoring into the Diagnosis and Management of Immune-Related Adverse Events
Abstract
Early detection of immune-related adverse events (irAEs) remains a major clinical gap in spite of their potential severity and the established feasibility of electronic patient-reported outcome (ePRO) symptom monitoring. As the use of immune checkpoint inhibitors increases and the number of people exposed to irAEs rises, progress toward ePRO clinical implementation will depend on smarter system design and implementation-focused research.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Cancer survivorship and care
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- Default Digital Object Group
- Publication date
- 12 March 2026
- Language
- EN
- Document type
- Dataset